Trials / Completed
CompletedNCT02540798
Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?
Do Increased Levels of Anxiety Decrease the Reproducibility of Symptoms During Urodynamic Studies in Women?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Sandwell & West Birmingham Hospitals NHS Trust · Academic / Other
- Sex
- Female
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study will look at how pre-test anxiety levels affect the reproducibility of symptoms during routine urodynamic testing in women. Urodynamics is a test that assesses the function of the lower urinary tract, including the bladder.
Detailed description
The results of urodynamic tests often determine treatment for patients, which may include bladder retraining, medication and/or surgery. Thus, it is important for the results of urodynamics to be accurate and representative of the patient's symptoms outside of the clinic. Pre-test anxiety levels in women undergoing urodynamics will be measured using a validated questionnaire HADS (Hospital anxiety and depression scale). The patient, prior to their routine urodynamics test, will fill out this self-administered questionnaire. Reproducibility of patient symptoms will be measured using a non-validated quantitative bladder test assessment. The patient will fill out this self-administered quantitative bladder assessment after their urodynamics test. The pre-test anxiety and symptom reproducibility variables will be correlated against each other to assess whether there is correlation between the two. A Spearman Rho test will be used to assess the strength of the relationship.
Conditions
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-11-01
- Completion
- 2016-04-01
- First posted
- 2015-09-04
- Last updated
- 2016-10-24
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02540798. Inclusion in this directory is not an endorsement.